Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: The New Company?

RE: The New Company?

posted on Jul 31, 2005 11:05AM
Thanks,

But my issues are in the details. I imagine the overwhelming revenue will be in royalty payments

and not a large backlog payment.I perceive that they are keeping this private, while they do the Fujitsu deal.

Perhaps keeping the companies they are negoiating with in the dark as well, tho I don`t know how they can do that

or how anyone would sign a contract without knowing relevent details. I am very curious as to this stradegy they are using. Why keep us in the dark.There has to be some reason and every scenerio I come up with has a

logical counter point.

Thanks

Share
New Message
Please login to post a reply